We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
South Korea’s financial regulator Securities and Futures Commission (SFC) has issued its final decision regarding Samsung BioLogic’s alleged breach of accounting rules.